Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 November, 2018 18:56 IST
Lupin receives USFDA approval for pregnancy prevention tablets
Source: IRIS | 14 Jun, 2018, 03.47PM
Comments  |  Post Comment

Pharma major Lupin announced that it has received final approval fonts Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and LevomefolateCalcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Bayer HealthCare Pharmaceutical Inc.'s (Bayer) Beyaz®Tablets.

Lupin's Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg, are the generic equivalent of Bayer's Beyaz® Tablets. It is indicated for use by women to:

> prevent pregnancy;

> treat symptoms of premenstrual dysphoric disorder (PMDD) for women who choose to use an oral contraceptive for contraception;

> treat moderate acne for women at least 14 years old, only if the patient desires an oral contraceptive for birth control; and

> raise folate levels in women who choose to use an oral contraceptive for contraception

Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg had annual sales of approximately U5D 82.2 million in the US (IOWA MATApril 2018).

Shares of the company gained Rs 47.7, or 5.58%, to trade at Rs 902.00. The total volume of shares traded was 391,151 at the BSE (3.30 p.m., Thursday).





Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Gayatri Projects declared as lowest bidder for project worth Rs 1.62 bn - 20-Nov-2018 14:55
Ramco Systems wins contract from leading casino and resorts provider - 20-Nov-2018 14:52
Zydus Cadila receives tentative approval for Deferasirox tablets - 20-Nov-2018 14:49
Kridhan Infra arm wins orders worth Rs 1.95 bn - 20-Nov-2018 09:35
Glenmark Pharma receives approval for Azelaic acid gel - 20-Nov-2018 09:31
PSP Projects' total work order stands at Rs 8.04 bn in FY19 - 20-Nov-2018 09:28
TCS partners with SAP to build intelligent rail digital maintenance solution - 20-Nov-2018 09:27
Zydus receives final approval from USFDA for Abacavir & Lamivudine Tablets and Fondaparinux Sodium Injection - 19-Nov-2018 09:51
Infosys starts construction of U.S education center in Indianapolis - 19-Nov-2018 09:41
Infosys completes formation of JV with Temasek - 19-Nov-2018 09:37
SPML Infra wins arbitration award against Jharkhand Urja Utpadan Nigam - 19-Nov-2018 09:34
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer